Bridgeway Capital Management’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1K | Hold |
19,800
| – | – | ﹤0.01% | 1173 |
|
|
2025
Q1 | $11.3K | Sell |
19,800
-208,600
| -91% | -$119K | ﹤0.01% | 1167 |
|
|
2024
Q4 | $327K | Sell |
228,400
-7,100
| -3% | -$10.2K | 0.01% | 904 |
|
|
2024
Q3 | $455K | Buy |
235,500
+67,500
| +40% | +$130K | 0.01% | 886 |
|
|
2024
Q2 | $521K | Sell |
168,000
-25,000
| -13% | -$77.5K | 0.01% | 849 |
|
|
2024
Q1 | $1.01M | Hold |
193,000
| – | – | 0.02% | 740 |
|
|
2023
Q4 | $625K | Buy |
193,000
+11,100
| +6% | +$36K | 0.01% | 887 |
|
|
2023
Q3 | $464K | Hold |
181,900
| – | – | 0.01% | 897 |
|
|
2023
Q2 | $1.07M | Hold |
181,900
| – | – | 0.03% | 714 |
|
|
2023
Q1 | $518K | Buy |
181,900
+79,600
| +78% | +$227K | 0.01% | 877 |
|
|
2022
Q4 | $206K | Buy |
+102,300
| New | +$206K | 0.01% | 1079 |
|